Author

Anne Roshan Joseph

Observed name: A.R. Joseph

OpenAlex ID: A5019718878

Early Results from a Phase-2 Study of Varnimcabtagene Autoleucel (IMN-003A), a First-in-India Industry CD19-Directed CAR-T Cell Therapy with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies (IMAGINE Study)

2022 · Sharat Damodar, Sunil Bhat, et al. · Blood · 8

Varnimcabtagene Autoleucel (IMN-003A): Pharmacokinetic Profile with Predominant Naïve and Central Memory Phenotype Demonstrates Sustained In Vivo Persistence and Durable Responses in a First-in-India Industry Phase-2 Study (IMAGINE)

2023 · Sunil Bhat, Sharat Damodar, et al. · Blood · 3

Response, Peak and Persistence of Varnimcabtagene Autoleucel (IMN-003A), First-in-India Industry CD19-Directed CAR-T Cell Therapy, with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies: Early Results (IMAGINE Study)

2022 · Sunil Bhat, Sharat Damodar, et al. · Blood · 2

Cytokine Profile Following Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies in the First-in-India Industry Phase-2 Study (IMAGINE)

2023 · Sharat Damodar, Sunil Bhat, et al. · Blood · 1

Varnimcabtagene Autoleucel (IMN-003A): Differences in T Cell Subset Phenotype in B-ALL and B-NHL Cohorts Did Not Influence Efficacy Outcomes in the Phase-2 Study (IMAGINE)

2023 · Sunil Bhat, Sharat Damodar, et al. · Blood · 1

Immunotherapy: IMAGINE STUDY: INTERIM TRANSLATIONAL OUTCOMES OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FROM FIRST-IN-INDIA PHASE 2 TRIAL FOR ANTI CD19-CAR-T CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY B CELL MALIGNANCIES

2023 · S. Bhat, S. Damodar, et al. · Cytotherapy · 1

Varnimcabtagene autoleucel in relapsed or refractory B-cell malignancies

2025 · Sharat Damodar, Sunil Bhat, et al. · Blood Immunology & Cellular Therapy

P1364: Pharmacokinetic Profile of Varnimcabtagene Autoleucel (imn-003a), First-in-india Industry Cd19-directed Car-t Cell Therapy for Patients With Relapsed/ Refractory B Cell Malignancies (imagine Study)

2023 · Pankaj Malhotra, Sunil Bhat, et al. · HemaSphere

Works count: 8

Citation count: 16

H-index: 2

I10-index: